Barclays PLC Purchases 3,991 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

Barclays PLC Purchases 3,991 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)

Barclays PLC lifted its position in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL – Free Report) by 14.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 31,336 shares of the biotechnology company’s stock after purchasing an additional 3,991 shares during the period. Barclays PLC owned 0.18% of Rigel Pharmaceuticals worth $528,000 as of its most re…

Rigel Pharmaceuticals (NASDAQ:RIGL) Given New $23.00 Price Target at Cantor Fitzgerald

Rigel Pharmaceuticals (NASDAQ:RIGL – Free Report) had its price target upped by Cantor Fitzgerald from $20.00 to $23.00 in a research note published on Wednesday morning,Benzinga reports. They currently have a neutral rating on the biotechnology company’s stock. RIGL has been the subject of several other reports. HC Wainwright reissued a “buy” rating and issued […]